Company Novartis Srl with Fiscal Code 16306392
recorded a turnover of 2024 of
651.192,
with a net profit of
131.189
and having an average number of employees of
8.
The company operates in the field of Activităţi de arhitectură having the NACE code 7111.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Novartis Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
9.195
45.566
107.942
147.734
232.167
310.292
420.114
663.097
867.171
651.192
Total Income - EUR
14.939
45.566
107.959
147.757
232.230
310.514
420.928
665.196
880.426
659.567
Total Expenses - EUR
14.322
30.168
94.576
78.925
111.053
193.698
276.733
484.115
601.537
507.907
Gross Profit/Loss - EUR
617
15.398
13.383
68.832
121.177
116.816
144.196
181.081
278.889
151.660
Net Profit/Loss - EUR
340
14.031
12.226
67.355
119.319
114.353
141.336
176.269
271.264
131.189
Employees
1
1
1
3
3
5
7
6
8
8
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales decreased by -24.5%, from 867.171 euro in the year 2023, to 651.192 euro in 2024.
The Net Profit decreased by -138.559 euro, from 271.264 euro in 2023, to 131.189 in the last year.
Check the financial reports for the company - Novartis Srl
Financial Rating - NOVARTIS SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Novartis Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Novartis Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Novartis Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
267.832 euro in 2024 which includes Inventories of
0 euro, Receivables of
106.264 euro and cash availability of
161.569 euro.
The company's Equity was valued at
597.905 euro, while total Liabilities amounted to
88.590 euro.
Equity increased by 17.442 euro, from 583.725 euro in 2023, to 597.905 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Novartis Srl